Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC
Clinical trial NCT02658097 · COMPLETED
Trial details
- NCT number
- NCT02658097
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-07
- Primary completion
- 2022-02-26
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.